Functional confirmation of Gitelman's syndrome mutations in Japanese

Hypertension Research

Volumn 28, Issue 10, 2005, Pages 805-809

  Naraba, Hiroaki ^a   Kokubo, Yoshihiro ^a   Tomoike, Hitonobu ^a   Iwai, Naoharu ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Blood pressure; Gitelman's syndrome; SLC12A3

Indexed keywords

COMPLEMENTARY DNA; SODIUM 22; SODIUM CHLORIDE COTRANSPORTER; COTRANSPORTER; DRUG RECEPTOR; SLC12A3 PROTEIN, HUMAN; SODIUM;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; GENE EXPRESSION; GENE FREQUENCY; GENE MUTATION; GENETIC POLYMORPHISM; GITELMAN SYNDROME; JAPANESE; NONHUMAN; SITE DIRECTED MUTAGENESIS; ANIMAL; CHO CELL; GENETIC TRANSFECTION; GENETICS; HAMSTER; HETEROZYGOTE; HUMAN; KIDNEY TUBULE DISORDER; METABOLISM; MUTATION; PHYSIOLOGY; SYNDROME;

ANIMALS; CHO CELLS; CRICETINAE; HETEROZYGOTE; HUMANS; MUTATION; RECEPTORS, DRUG; RENAL TUBULAR TRANSPORT, INBORN ERRORS; SODIUM; SYMPORTERS; SYNDROME; TRANSFECTION;

EID: 33644867836     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.28.805     Document Type: Article

References (14)

1. Simon DB, Nelson-Williams C, Bia MJ, et al: Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet 1996; 12: 24-30.
2. Cruz DN, Simon DB, Nelson-Williams C, et al: Mutations in the Na-Cl cotransporter reduce blood pressure in human. Hypertension 2001; 37: 1458-1464.
3. Tago N, Kokubo Y, Inamoto N, et al: A high prevalence of Gitelman's syndrome mutations in Japanese. Hypertens Res 2004; 27: 327-331.
4. De Jong JC, Willems PH, Goossens M, et al: Effects of chemical chaperones on partially retarded NaCl cotransporter mutants associated with Gitelman's syndrome in a mouse cortical collecting duct cell line. Nephrol Dial Transplant 2004; 19: 1069-1076.
5. Mannami T, Baba S, Ogata J: Potential of carotid enlargement as a useful indicator affected by high blood pressure in a large general population of a Japanese city: the Suita study. Stroke 2000; 31: 2958-2965.
6. Ono K, Iwanaga Y, Mannami T, et al: Epidemiological evidence of an association between SLC6A2 gene polymorphism and hypertension. Hypertens Res 2003; 26: 685-689.
7. Iwai N, Katsuya T, Mannami T, et al: Association between SAH, an acyl-CoA synthetase gene, and hypertriglyceridemia, obesity, and hypertension. Circulation 2002; 105: 41-47.
8. Shioji K, Kokubo Y, Mannami T, et al: Association between hypertension and the α-adducin, β1-adrenoreceptor and G-protein β3 subunit genes in the Japanese population; the Suita Study. Hypertens Res 2004; 27: 31-37.
9. Freeze HH: Human disorders in N-glycosylation and animal models. Biochim Biophys Acta 2002; 1573: 388-393.
10. De Jong JC, Van Der Vliet WA, Van Den Heuvel LP, et al: Functional expression of mutations in the human NaCl cotransporter: evidence for impaired routing mechanisms in Gitelman's syndrome. J Am Soc Nephrol 2002; 13: 1442-1448.
11. Monkawa T, Kurihara I, Kobayashi K, Hayashi M, Saruta T: Novel mutations in thiazide-sensitive Na-Cl cotransporter gene of patients with Gitelman's syndrome. J Am Soc Nephrol 2000; 11: 65-70.
12. Fukuyama S, Okudaira S, Yamazato S, Yamazato M, Ohta T: Analysis of renal tubular electrolyte transporter genes in seven patients with hypokalemic metabolic alkarosis. Kidney Int 2003; 64: 808-816.
13. Maki N, Komatsuda A, Wakui H, et al: Four novel mutations in the thiazide-sensitive Na-Cl co-transporter gene in Japanese patients with Gitelman's syndrome. Nephrol Dial Transplant 2004; 19: 1761-1766.
14. Gamba G: Molecular physiology and pathophysiology of electroneutral cation-chroride cotransporters. Physiol Rev 2005; 85: 423-493.